Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blood neoplasia

Showing results (1-10 of 246) with videos related to

Pageof 25
Sort By:
Blood Neoplasia|September 15, 2025
Risk factors and clinical impact of cytomegalovirus DNAemia in patients with multiple myeloma treated with teclistamabCharles Pei, Zeinab El Boghdadly, Lisa Blackburn, et al.
Blood Neoplasia|September 15, 2025
Response and outcomes of patients with <i>IDH1/2-</i> mutated accelerated/blast-phase myeloproliferative neoplasmsLeah A Goldberg, James J Yoon, Hannah Johnston, et al.
Blood Neoplasia|September 22, 2025
Posttranscriptional activity of eIF4E contributes to HoxA9-driven leukemogenesisFang Zhou, Biljana Culjkovic-Kraljacic, Christian Bach, et al.
Blood Neoplasia|December 24, 2025
Ipilimumab with and without nivolumab in patients with classic Hodgkin lymphoma with progression after PD-1 blockadeReid W Merryman, Justin Kline, Robert A Redd, et al.
Blood Neoplasia|December 22, 2025
Do all patients with chronic phase CML require a diagnostic bone marrow biopsy in the modern TKI era?Noel F T Fong, David M Ross, David T Yeung, et al.
Blood Neoplasia|June 2, 2025
CD302 predicts achievement of deep molecular response in patients with chronic myeloid leukemia treated with imatinibChung Hoow Kok, Yazad Irani, Jade Clarson, et al.
Blood Neoplasia|June 2, 2025
Real-world outcomes of newly diagnosed AML treated with venetoclax and azacitidine or low-dose cytarabine in the UK NHSJad Othman, Ho Pui Jeff Lam, Sarah Leong, et al.
Blood Neoplasia|June 2, 2025
Addition of navitoclax to ruxolitinib for patients with myelofibrosis with progression or suboptimal responseNaveen Pemmaraju, Tim C P Somervaille, Francesca Palandri, et al.
Blood Neoplasia|June 2, 2025
Targeting transcription-replication conflicts using G-quadruplexes stabilizers in multiple myelomaLaure Dutrieux, Sara Ovejero, Antoine Guillemin, et al.
Blood Neoplasia|June 2, 2025
Clinical outcomes of patients with newly diagnosed large B-cell lymphoma in a safety-net hospital systemJun Y Jiang, Chijioke Nze, Danielle Guffey, et al.
Pageof 25

Showing results (1-10 of 246) with videos related to

Sort By:
Pageof 25
Blood Neoplasia|September 15, 2025
Risk factors and clinical impact of cytomegalovirus DNAemia in patients with multiple myeloma treated with teclistamabCharles Pei, Zeinab El Boghdadly, Lisa Blackburn, et al.
Blood Neoplasia|September 15, 2025
Response and outcomes of patients with <i>IDH1/2-</i> mutated accelerated/blast-phase myeloproliferative neoplasmsLeah A Goldberg, James J Yoon, Hannah Johnston, et al.
Blood Neoplasia|September 22, 2025
Posttranscriptional activity of eIF4E contributes to HoxA9-driven leukemogenesisFang Zhou, Biljana Culjkovic-Kraljacic, Christian Bach, et al.
Blood Neoplasia|December 24, 2025
Ipilimumab with and without nivolumab in patients with classic Hodgkin lymphoma with progression after PD-1 blockadeReid W Merryman, Justin Kline, Robert A Redd, et al.
Blood Neoplasia|December 22, 2025
Do all patients with chronic phase CML require a diagnostic bone marrow biopsy in the modern TKI era?Noel F T Fong, David M Ross, David T Yeung, et al.
Blood Neoplasia|June 2, 2025
CD302 predicts achievement of deep molecular response in patients with chronic myeloid leukemia treated with imatinibChung Hoow Kok, Yazad Irani, Jade Clarson, et al.
Blood Neoplasia|June 2, 2025
Real-world outcomes of newly diagnosed AML treated with venetoclax and azacitidine or low-dose cytarabine in the UK NHSJad Othman, Ho Pui Jeff Lam, Sarah Leong, et al.
Blood Neoplasia|June 2, 2025
Addition of navitoclax to ruxolitinib for patients with myelofibrosis with progression or suboptimal responseNaveen Pemmaraju, Tim C P Somervaille, Francesca Palandri, et al.
Blood Neoplasia|June 2, 2025
Targeting transcription-replication conflicts using G-quadruplexes stabilizers in multiple myelomaLaure Dutrieux, Sara Ovejero, Antoine Guillemin, et al.
Blood Neoplasia|June 2, 2025
Clinical outcomes of patients with newly diagnosed large B-cell lymphoma in a safety-net hospital systemJun Y Jiang, Chijioke Nze, Danielle Guffey, et al.
Pageof 25